Zymergi LogoCart

483 Document: Aspire Pharmaceuticals, Inc., Feb 3, 2022

FDANews 483 Aspire Pharmaceuticals, Inc. Feb 3 2022 top
Charlotte P. Chang FDA Investigator Annet R. Rajan FDA Investigator Lata C. Mathew FDA Investigator Justin A. Boyd FDA Investigator Karen A. Spencer FDA Investigator

On Feb 03, 2022, the FDA inspected Aspire Pharmaceuticals, Inc.'s Somerset site. Explore the inspectional observations.